AVTX - Avalo Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-01-03)
Last
 8.39		 Change
 ⇓ -0.04   (-0.47%)		 Volume
  88,966
Open
 8.55		 High
 8.98		 Low
 8.00
8EMA (Daily)
 8.41		 40EMA (Daily)
 9.68		 50EMA (Daily)
 9.87		 STO (Daily)
 20.397		 MACD Hist (Daily)
 -0.083
8EMA (Weekly)
 9.447		 40EMA (Weekly)
 9.66		 50EMA (Weekly)
 9.30		 STO (Weekly)
 14.336		 MACD Hist (Weekly)
 -0.851
Company Profile
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, AVTX-006, AVTX 800 programs (AVTX-801, AVTX-802, and AVTX-803).
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com